Arcadia Biosciences (NASDAQ: RKDA) reported Q4 EPS of ($0.13), $0.03 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $540 thousand versus the consensus estimate of $1 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.